Cardiac hypertrophy in hypertension
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985823%3A_____%2F13%3A00392837" target="_blank" >RIV/67985823:_____/13:00392837 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Cardiac hypertrophy in hypertension
Original language description
Hypertension often results in left ventricular hypertrophy (LVH) defined as a major risk factor for cardiovascular morbidity and mortality. Although in animals the LVH can be prevented by pharmacology therapy, in man LVH can be reduced only to a limitedextend. Moreover, if the therapy is not applied in a precise developmental windows, the results may be subtle or none. It is evident that gender differences could play also signifiant role
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
ED - Physiology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GAP304%2F12%2F0259" target="_blank" >GAP304/12/0259: Mutual interactions of various vasoactive systems, reactive oxygen species and G proteins in experimental hypertension</a><br>
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Cardiac Adaptations : Molecular Mechanisms
ISBN
978-1-4614-5202-7
Number of pages of the result
17
Pages from-to
251-267
Number of pages of the book
465
Publisher name
Springer
Place of publication
New York
UT code for WoS chapter
—